Alto Neuroscience, Inc.'s total assets for Q1 2025 were $171.91M, a decrease of -3.17% from the previous quarter. ANRO total liabilities were $32.82M for the fiscal quarter, a 25.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.